作者
Hia Ghosh,Ruchit V. Patel,E. L. Woodward,Noah F. Greenwald,Varun Bhave,Eduardo A. Maury,Gregory Cello,Samantha E. Hoffman,Yvonne Li,Hersh Gupta,Gilbert Youssef,Liam F. Spurr,Jayne Vogelzang,Mehdi Touat,Frank Dubois,Andrew D. Cherniack,Xiaopeng Guo,Sherwin Tavakol,Gino Cioffi,Neal I. Lindeman,Azra H. Ligon,E. Antonio Chiocca,David A. Reardon,Patrick Y. Wen,David M. Meredith,Sandro Santagata,Jill S. Barnholtz‐Sloan,Keith L. Ligon,Rameen Beroukhim,Wenya Linda Bi
摘要
With the significant shift in the classification, risk stratification, and standards of care for gliomas, we sought to understand how the overall survival of patients with these tumors is impacted by molecular features, clinical metrics, and treatment received.